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Abstract
Background: A first step to offer community-dwelling older persons proactive care is to identify those at risk of
functional decline within a year. This study investigates the predictive value of registered information, questionnaire
and GP-opinion on functional decline.
Methods: In this cohort study, embedded within the ISCOPE-trial, participants (≥75 years) completed the ISCOPE-
screening questionnaire on four health domains. GPs gave their opinion on vulnerability of participants. Functional
status was measured at baseline and 12 months (Groningen Activities Restriction Scale [GARS]). The outcome was
functional decline (death, nursing home admission, 10% with greatest functional decline). The predictive value of
pre-selected variables (age, sex, polypharmacy, multimorbidity, living situation; GPs’ opinion on vulnerability,
number of domains with problems [ISCOPE-score]) was compared with the area under the curves (AUC) for logistic
regression models.
Results: 2018 of the 2211 participants (median age 82.1 years [IQR 78.8–86.5], 68.0% female, median GARS 31 [IQR
24–41]) were visited at 12 months (median GARS 34 [IQR 26–44]). 394 participants (17.8%) had functional decline
(148 died, 45 nursing home admissions, 201 with greatest functional decline). The AUC for age and sex was 0.602,
increasing to 0.620 (p = 0.029) with polypharmacy, multimorbidity and living situation. The GPs’ opinion added more
(AUC 0.672, p < 0.001) than the ISCOPE-score (AUC 0.649, p = 0.007). AUC with all variables was 0.686 (p = 0.016), and
0.643 for GPs’ opinion alone.
Conclusions: The GPs’ opinion and ISCOPE-score improve this prediction model for functional decline based on
readily available variables. GPs could identify older patients for further assessment with their clinical judgement.
Trial registration: Netherlands trial register, NTR1946. Registered 10 August 2009.
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Background
It is important for older persons to be able to perform
the basic activities of daily living (BADL) and instrumen-
tal activities of daily living (IADL). Previous research has
shown that being independent has a positive effect on
the quality of life [1, 2]. Therefore, many (inter)national
healthcare programs aim to prevent and delay disability
affecting independence, nursing home admission and
mortality, with proactive healthcare [3–5]. Despite some
promising results described by Beswick et al. [6], a more
recent review shows that these programs often have
limited effects [7].
A first and necessary step in proactive healthcare is to
identify older persons at risk of functional decline and
disability [8]. The disappointing effects of health care
programs might be explained by inappropriate selection
of the target population [9]. Some risk factors known to
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be associated with functional decline [10–14] and some
predictors of dependency in BADL have been identified
among specific populations [15, 16]. However, for
community-dwelling older persons, the evidence to
predict a decline in IADL and BADL remains limited
and inconclusive. Even the value of several geriatric
screening tools in prediction of functional decline ap-
pears to be limited [17]. More effective tools, both with
a higher predictive value and easy to use in clinical prac-
tice, are needed. In the Netherlands, the general practi-
tioner (GP) is closest to the patient and might be best
able to identify those at risk of functional decline. Al-
though some studies include possible predictors easily
obtainable by the GP, the GPs’ clinical judgement and
the interaction of health issues are less often taken into
account [16, 18]. However, a recent study suggests the
possible importance of the GPs’ judgement in predicting
adverse outcomes [19]. The GPs’ judgement of func-
tional status is a predictor that requires no additional in-
vestments in time and finances. It is therefore important
to examine if the predictive value justifies to add this
judgement to the diagnostic pathway for older patients.
Therefore, this study investigates whether the predictive
value of several pre-selected clinical variables on func-
tional decline which are readily available for the GP (age,
sex, polypharmacy, multimorbidity and living situation)
can be improved by adding the GPs’ opinion on the vul-
nerability of their patients and scores on the ISCOPE
screening questionnaire on four health domains.
Methods
Study design and population
The present study is a longitudinal follow-up study em-
bedded in the Integrated Systemic Care for Older People
(ISCOPE) study. The ISCOPE Study was a large health-
care innovation trial conducted in the Netherlands [3].
Briefly, in ISCOPE, all eligible patients (≥75 years) in
59 general practices (n = 11,476) were invited (between
September 2009 and September 2010) to participate. At
baseline, they received the postal ISCOPE screening
questionnaire (Additional file 1) with 23 questions on
four health domains (somatic, functional, psychological
and social). The ISCOPE-score is the number of
domains with problems (i.e. when the participants expe-
riences ≥2 items in this domain as a problem). GPs were
asked to rate their opinion on the vulnerability of the
participant on a three point scale (not vulnerable,
possibly vulnerable, vulnerable). No guidelines were pro-
vided for interpretation of the term ‘vulnerable’ [20].
A selection of participants (15% with ISCOPE-score 0/1,
60% with ISCOPE-score 2, and 100% with ISCOPE-score
3/4) was visited at home by research nurses at baseline
and at 12-month follow-up to collect more information
on their functional status with the Minimal Data Set
(MDS) questionnaire [21] and the Groningen Activities
Restriction Scale (GARS) [22]. Participants were included
in this analysis if data on their functional status and on all
pre-selected variables were available at baseline and at
12 months, or if these data were available at baseline but
the participant died or was admitted to a nursing home
during the study period. All participants provided a writ-
ten informed consent. For participants with cognitive
problems this was provided by a representative.
Pre-selected variables
As possible predictors we pre-selected variables known/
or easy to obtain by the GP: age, sex, polypharmacy (> 3
medications), multimorbidity (> 1 of the following
diseases: diabetes, stroke/cerebrovascular accident, myo-
cardial infarction, heart failure, cancer, COPD/asthma,
urine incontinence, osteoarthrosis hip/knee, osteopor-
osis, fracture, dizziness with falling, prostate symptoms,
depression, anxiety disorder, dementia, hearing or visual
problems), and living situation (home for older persons
or independent, with or without others). All variables
were self-reported in the ISCOPE screening question-
naire or the MDS questionnaire.
Outcome measurement
Functional status was measured with the GARS (11
questions on BADL and 7 on IADL). Scores per ques-
tion range from 1 point (I can do this fully independ-
ently, without any help) to 4 points (I can only do this
with someone’s help). The total score ranges from 18
(completely independent) to 72 points (highly
dependent) [22]. There has been no cut-off value defined
for functional decline [23].
A low GARS at baseline can increase more than a high
GARS at baseline (ceiling effect). Therefore we calculated
the proportional increase in GARS from the potential in-
crease in GARS from baseline ([GARS at 12 months –
GARS at baseline] / [72 - GARS at baseline]) for each par-
ticipant. Due to this correction, participants with the same
increase in GARS at baseline, but a different potential in-
crease in GARS, have a different proportional increase in
GARS. Participants with the same GARS at baseline, and
therefore the same potential increase in GARS, are com-
parable concerning their functional status. An increase in
GARS within a group of participants with a comparable
potential increase in GARS is likely to have a comparable
impact on daily life. Therefore, we compared participants
with other participants with the same potential increase in
GARS. For this aim, the study population was divided into
six categories according to their baseline GARS (18–26,
27–35, 36–44, 45–53, 54–62, 63–72). The number of par-
ticipants per category could differ. It can be expected that
the impact on daily life is larger for participants who have
a larger proportional increase in GARS compared to other
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participants in their group with the same potential in-
crease in GARS. Because of this, participants were con-
sidered to have a relevant functional decline when their
proportional increase in GARS was higher than the pro-
portional increase of 90% of the participants in their cat-
egory. Those participants who were not visited after
12 months because they had died or were admitted to a
nursing home, were also considered to have a relevant
functional decline.
Statistical methods
Patient characteristics are described as proportions,
except for age and baseline GARS for which medians are
reported. Baseline characteristics of individuals not
included in the analysis were compared with those of
the study participants.
Associations between the pre-selected baseline
variables and a relevant functional decline were tested
with univariate logistic regression analysis. The different
models were compared with the area under the curve
(AUC) for the different receiver operating characteristics
curves (ROC curves) in a step-wise manner. The ROC
curve is a plot of the sensitivity against one minus the
specificity for different cut-off points. The reference line
is the line if the model has no discriminative power
(AUC 0.5). The accuracy is poor with an AUC between
0.60 to 0.70, fair between 0.70 to 0.80, good between
0.80 to 0.90 and excellent between 0.90 to 1.0. The first
model included age and sex. In separate analyses we
added polypharmacy, multimorbidity and living situation
(model 2), the ISCOPE-score (model 3), the GPs’ opin-
ion on vulnerability (model 4), and the combination of
the ISCOPE-score and the GPs’ opinion on vulnerability
(model 5). In additional analyses we combined age, sex,
polypharmacy, multimorbidity and living situation with
either the ISCOPE-score (model 6), the GPs’ opinion on
vulnerability (model 7), or both (model 8) (Fig. 1). The
AUC for the GPs’ opinion alone is reported. Nagelk-
erkes’ R2 is reported for each model as well.
Sensitivity analysis
After stratification into six groups based on the baseline
GARS, additional ROC analyses were performed to
check whether it was justified to combine these groups
in the analysis.
As a sensitivity analysis we repeated the main ROC
analyses but excluding those participants with a max-
imum baseline GARS-score of 72, since their score on
the GARS could not increase.




At baseline 7285 participants (response 63.5%) completed
the ISCOPE screening questionnaire and 2713 (37.2%)
were visited at home. Included in the present analysis (n
= 2211) were participants with a GARS-score at baseline
and at 12 months (n = 2018), those admitted to a nursing
home (n = 45) and those who died (n = 148) (Fig. 2).
Median age was 82.1 (IQR 78.8–86.5) years, 68.0% was
female and median GARS was 31 (IQR 24–41); 91% of
the participants had multimorbidity and 67.9% polyphar-
macy. GPs considered 31.7% of the participants vulner-
able and 40.4% not vulnerable. Also, 9.0% of the
participants had an ISCOPE-score of zero and 16.9%
had an ISCOPE-score of four (Table 1).
At the 12-month follow-up, the GARS increased by 2
points (IQR − 1 to 6) to 34 (IQR 26 to 44) (n = 2018).
The cut-off for relevant functional decline (≥ p90) per
group was 19.7–100% of the potential increase
(Additional file 2).
Lost to follow-up and missing data
Participants were not included in this analyses when they
were not visited at 12 months (i.e. refused further partici-
pation (n = 218), were too ill (n = 18), or for other/un-
known reasons (n = 46)) or due to missing data at baseline
(n = 206), or at 12 months (n = 14) (Fig. 2). In general,
these participants were slightly older, had a higher baseline
Fig. 1 Steps in modelling of the ROC analyses
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GARS, more often lived in a home for older persons, were
more often vulnerable according to the GP, and had more
often a higher ISCOPE-score (Table 1).
Univariate association between pre-selected variables and
functional decline
The 394 participants (17.8%) with relevant functional de-
cline (148 died, 45 nursing home admissions, 201 with
greatest functional decline) during follow-up, had at base-
line a higher age, higher GARS, were less often female,
more often had polypharmacy, more often lived in a home
for older persons, were more vulnerable according to the
GP, and had a higher ISCOPE-score. Not associated with
functional decline was multimorbidity (Table 2).
Predictive value of pre-selected variables on a functional
decline
The AUC for age and sex was 0.602 (model 1). The AUC
increased to 0.620 (p = 0.0 29, compared to model 1) when
polypharmacy, multimorbidity and living situation were
Fig. 2 Flowchart of the study (n = 2211)
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added (model 2), to 0.644 (p < 0.001, compared to model 1)
with addition of the ISCOPE-score (model 3), and to 0.669
(p < 0.001, compared to model 1) with addition of GPs’
opinion on vulnerability (model 4). With a combination of
age, sex, ISCOPE-score and GPs’ opinion (model 5), the
AUC increased from 0.669 to 0.684 (p = 0.009, compared to
model 4). The predictive value of the more extensive model
with age, sex, polypharmacy, multimorbidity and living situ-
ation increased more with the GPs’ opinion on vulnerability
(model 7: AUC 0.672, p < 0.001, compared to model 2) than
with the ISCOPE-score (model 6: AUC 0.649, p = 0.007,
compared to model 2). With all variables included (model
8), the AUC increased from 0.672 to 0.686 (p = 0.016, com-
pared to model 7) (Table 3; Fig. 3). The AUC for the GPs’
opinion alone was 0.643.
Sensitivity analysis
After stratification of the population into six groups
according to the baseline GARS (n = 60–735), a similar
trend in the AUC was observed in the different group
(Additional file 2).
At baseline, 7 participants had a maximum GARS-score
of 72 which was the same at the 12-month follow-up; after
excluding these participants from the analysis, the results
did not change (data not shown).
Discussion
The predictive value of a model for functional decline
using variables readily available for the GP (age, sex,
polypharmacy, multimorbidity and living situation)
improves when the ISCOPE-score or the GPs’ opinion
on vulnerability is added to the model. The GPs’ opinion
alone has a predictive value of 0.643. Data readily avail-
able for the GP can be used in combination with the
GPs’ opinion to predict functional decline. If the GP is
not familiar with the patient, the ISCOPE-score can be
used instead of the GPs’ opinion with only a small loss
of discriminative power.
Table 1 Baseline characteristics of the study population (n = 2211) compared to baseline characteristics of participants not included
in this study (n = 502)
Study population n = 2211 Not includedan = 502
Baseline characteristics n % n % p-valueb
Age at interview: years (median, IQR) 82.1 (78.8; 86.5) 82.6 (79.2; 87.3) 0.044
Baseline GARS (median, IQR) 31 (24; 41) 34 (25; 43) 0.006
Sex
Male 707 32.0 150 29.9 0.362
Female 1504 68.0 352 70.1
Polypharmacy n = 501
< 4 per day 710 32.1 185 36.9 0.039
4 or more per day 1501 67.9 316 63.1
Multimorbidity
Yes (> 1 chronic disease) 2011 91.0 458 91.2 0.843
No 200 9.0 44 8.8
Living situation n = 501
Independent, alone/with others 1985 89.8 429 85.6 0.007
Home for older persons 226 10.2 72 14.4
GP opinion on vulnerability n = 323
Not vulnerable 894 40.4 93 28.8 < 0.001
Possibly vulnerable 617 27.9 96 29.7
Vulnerable 700 31.7 134 41.5
ISCOPE-score on ISCOPE screening questionnaire
0 (no domain with problems) 198 9.0 49 9.8 0.099
1 (1 domain with problems) 183 8.3 34 6.8
2 (2 domains with problems) 614 27.8 119 23.7
3 (3 domains with problems) 843 38.1 195 38.8
4 (4 domains with problems) 373 16.9 105 20.9
aDue to missing data not all variables add up to 502 participants
bContinuous data compared with Mann-Whitney test, percentages with Pearson’s chi-square test
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Explanation of findings
This study is in line with earlier research that shows that
geriatric screening tools have limited use in predicting
functional decline [17]. It builds on previous work from
Van Kempen et al. who published a two-step tool (Easy-
care TOS) to identify older persons at risk for negative
outcomes after 1 year. The tool uses variables easy to ob-
tain in clinical practice in addition to the GPs’ opinion on
frailty [16]. In contrast with the present study a decline in
IADL was not considered to be a negative outcome.
Also a small study from the Netherlands by Sutor-
ius et al. suggests that the GP predicts adverse
Table 2 Baseline characteristics: comparison of participants without (n = 1817) and with (n = 394) a relevant functional decline
(univariate logistic regression)
Relevant functional decline
Without decline (n = 1817; 82.2%) With decline (n = 394; 17.8%)
Characteristics n % n % Odds ratio 95% CI
Age in years (median, IQR) 81.8 (78.5–86.2) 83.5 (79.8–87.7) 1.06 1.04; 1.08
Baseline GARS (median, IQR) 30 (24–39) 36 (28–49) 1.04 1.03; 1.05
Sex
Male 559 30.8 148 37.6 ref
Female 1258 69.2 246 62.4 0.74 0.59; 0.93
Polypharmacy
< 4 per day 603 33.2 107 27.2 ref
4 or more per day 1214 66.8 287 72.8 1.33 1.05; 1.70
Multimorbidity
No 169 9.3 31 7.9 ref
Yes (> 1 chronic disease) 1648 90.7 363 92.1 1.20 0.81; 1.79
Living situation
Independent, alone/with others 1656 91.1 329 83.5 ref
Home for older persons 161 8.9 65 16.5 2.03 1.49; 2.77
GP opinion on vulnerability
Not vulnerable 802 44.1 92 23.4 ref
Possibly vulnerable 518 28.5 99 25.1 1.67 1.23; 2.26
Vulnerable 497 27.4 203 51.5 3.56 2.72; 4.67
ISCOPE-score on ISCOPE screening questionnaire
0 (no domain with problems) 179 9.9 19 4.8 ref
1 (1 domain with problems) 172 9.5 11 2.8 0.60 0.28; 1.30
2 (2 domains with problems) 508 28.0 106 26.9 1.97 1.17; 3.30
3 (3 domains with problems) 687 37.8 156 39.6 2.14 1.29; 3.54
4 (4 domains with problems) 271 14.9 102 25.9 3.55 2.10; 5.99
Table 3 Multivariate models to predict a relevant decline of functional status (n = 2211)
Variables included in the model AUC compared to delta AUC p-value R2a
Model 1 Age and sex 0.602 0.033
Model 2 model 1, polypharmacy, multimorbidity and living situation 0.620 model 1 0.018 0.029 0.042
Model 3 model 1 and ISCOPE-score 0.644 model 1 0.024 < 0.001 0.066
Model 4 model 1 and GP opinion on vulnerability 0.669 model 1 0.049 < 0.001 0.086
Model 5 model 1, ISCOPE-score and GP opinion on vulnerability 0.684 model 4 0.015 0.009 0.102
Model 6 model 2 and ISCOPE-score 0.649 model 2 0.029 0.007 0.069
Model 7 model 2 and GP opinion on vulnerability 0.672 model 2 0.052 < 0.001 0.090
Model 8 model 2, ISCOPE-score and GP opinion on vulnerability 0.686 model 7 0.014 0.016 0.105
aNagelkerke
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outcomes (6 year-mortality or long term care admis-
sion) better than several other methods to identify
frail older persons in primary care [19]. Although the
results could have been influenced since only one GP
judged the patients [20], this interesting finding sup-
ports the idea of the relevance of the GPs’ judgement
of the patient.
Research on this topic has its challenges because there
is no consensus on the definition of disability and func-
tional decline [24]. Most studies on the prediction of
functional decline use only a decline in BADL as
outcome [16] and sometimes include scores on IADL as
possible predictors [12, 25]. However, a decline in IADL
status is also relevant for older participants because it
has implications for their independence. Anderson et al.
and van Houwelingen et al. include IADL disability.
They describe disability as an unstable state that can
improve or worsen over time and they define categories
for disability, i.e. independent/no disability, disability in
IADL, (mild) disability in BADL, and institutionalisation
or death [11, 13]. Although these categories include
IADL disability, small changes in IADL or BADL per-
formance are difficult to detect. Therefore, in this study
we combined BADL and IADL in the primary outcome.
The definition used for a relevant functional decline is
rather complex but with this definition we compare par-
ticipants to other participants with the same functional
status at baseline, taking their own functional status at
baseline into account.
Strengths and limitations
The strengths of this large cohort study with participants
aged ≥75 years are that: 1) we included only those vari-
ables known by the GP combined with the GPs’ clinical
judgement and the ISCOPE-score, to develop a predic-
tion model feasible for clinical practice; 2) we used a
decline in BADL and IADL as the primary outcome
since both contribute to self-reliance and independence;
and 3) relevant patient characteristics and prospective
data on functional status were available for a large sam-
ple of community-dwelling older participants.
Some limitations also need addressing: 1) GPs were asked
their opinion on patients’ vulnerability at baseline. Earlier
research showed that GPs take somatic and psychological
characteristics into account, but weigh the functional and
social characteristics differently when assessing vulnerability
[20]; 2) a follow-up period > 12 months with repeated mea-
surements may be needed to reveal more subtle changes in
functional status; 3) reasons for drop-out may have been re-
lated to the outcome of the study. Since participants that
dropped-out were slightly older, had a higher baseline
GARS-score, lived more often in a home for older persons,
were more vulnerable according to the GP and had a higher
ISCOPE-score, the true predictive value may be higher than
we observed.
Implications for research and practice
To deliver proactive care in general practice, efficient
identification of older persons at risk for functional
Fig. 3 ROC curve of the different models predicting a relevant decline in functional status (n = 2211). Model 1: age and sex; Model 2: age, sex,
polypharmacy, multimorbidity and living situation; Model 5: age, sex, GP opinion and ISCOPE-score; Model 8: age, sex, polypharmacy,
multimorbidity, living situation, GP opinion and ISCOPE-score
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decline is important [8]. It appears that the prediction of
functional decline by readily available variables can be
improved by adding the GPs’ opinion, or the ISCOPE-score
when the GP is not familiar with the patient. This know-
ledge might be useful to select participants for a more
extensive evaluation.
To improve the prediction of functional decline and
identification of older persons at risk, a relevant out-
come measure needs to be defined: e.g., a relevant
cut-off for the measurement tools for functional decline,
a definition in terms of disability transitions [11, 13], or
a more personalised outcome measurement as goal
attainment scaling [26]. Also, other factors such as unex-
pected adverse health events (e.g. hip fracture, hospital
admissions, or the loss of a spouse or primary caregiver)
could be important predictors. Furthermore, we agree
with Sutorius et al. [19] that identification of older
persons at risk for a functional decline it only a first
step. Second should be establishing which older persons
at risk, are likely to benefit from pro-active care to
prevent a functional decline. Research on these topics
might offer new opportunities for prevention of disabil-
ity and dependence.
Conclusions
The predictive value of a model for functional decline
using variables readily available for the GP (age, sex,
polypharmacy, multimorbidity and living situation)
improves when the ISCOPE-score or the GPs’ opinion
on vulnerability is added to the model. The GPs’ opinion
alone has a predictive value of 0.643. Until it becomes
possible to predict a risk of functional decline more
accurately, it seems beneficial to use the clinical judge-
ment of GPs to select older persons in probable need of
more extensive assessment.
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